Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With ChemotherapyNasser H. Hanna, Paul A. Bunn, Frances A. Shepherd et al.|Journal of Clinical Oncology|2004Cited by 2.4k
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid CancerRazelle Kurzrock, Ravi Salgia, Roger B. Cohen et al.|Journal of Clinical Oncology|2011Cited by 551